Nitric oxide induction as a novel immunoepidemiological target in malaria‐infected patients from endemic areas of the Islamic Republic of Iran

References

• World Health Organization. A global strategy for malaria control. WHO, Geneva 2003
   Google Scholar
• Edrissian G. H. Malaria history and status in Iran. J School Pub Health Inst Pub Health Res 2002; 1: 50–60
   Google Scholar
• Manouchehri A. V., Zaim M., Emadi M. A review of malaria in Iran, (1975–90). J Am Mosq Contr Assoc 1992; 8: 381–5
   PubMed Web of Science ®Google Scholar
• Zakeri S., Talebi Najafabadi S., Zare A., Dinparast Djadid N. Detection of malaria parasites by nested PCR in south‐eastern, Iran: evidence of highly mixed infections in Chahbahar district. Malaria J 2002; 1: 1–6
   PubMedGoogle Scholar
• Sadrizadeh B. Malaria in the world, in the eastern Mediterranean region and in Iran. 2001; 1–13, Communicable Disease Control (DCD), World Health Organization, Regional Office for the Eastern Mediterranean, Alexandria, Egypt. WHO/EMRO
   Google Scholar
• Zakeri S., Naimi P., Zare M., Zand Haghighi M., Dinparast‐Djadid N. Molecular evidence on changing pattern of mixed Plasmodium falciparum and P. vivax infections during year‐round transmission of malaria in Chahbahar, Iran. Iranian Biomed J 2004; 8: 89–93
   Google Scholar
• Edrissian G. H., Afshar A., Sayedzadeh A., Mohsseni G., Satvat M. T. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine‐pyrimethamine in the malarious areas of Iran. J Trop Med Hyg 1993; 96: 237–40
   PubMedGoogle Scholar
• Zaim M., Naseri‐Nejad D., Azoordgan F., Emadi A. M. Knowledge and practice of residents about malaria in southeast Iran. Acta Trop 1997; 64: 123–30
   PubMedGoogle Scholar
• Assmar M., Terhovanessian A., Jahani M. R., Nahrevanian H., Amirkhani A., Piazak N., et al. Molecular epidemiology of malaria disease in endemic areas of Iran. SE Asian J Trop Med Pub Health 2003; 34: 15–9
   PubMedGoogle Scholar
• Zakeri S., Dinparast Djadid N., Zeinali S. Sequence heterogenicity of the merozoite surface protein‐1 gene (MSP‐1) of Plasmodium vivax wild isolates in southeastern Iran. Acta Trop 2003; 88: 91–7
   PubMedGoogle Scholar
• Edrissian G. H. Malaria history and status in Iran. J Sch Public Health Inst Public Health Res 2002; 1: 50–60
   Google Scholar
• Zaim M. Malaria control in Iran; present and future. J Am Mosq Control Assoc 1987; 3: 392–6
   PubMed Web of Science ®Google Scholar
• Hommel M. Immunology of malaria. WHO, Health co‐operation papers, Quaderni di cooperazion sanitaria. World Health Organisation, Geneva 1996; 53–70
   Google Scholar
• Bogdan C., Rollinghoff M., Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12: 64–76
   PubMed Web of Science ®Google Scholar
• Ghigo D., Todde R., Ginsburg H., Costamagna C., Gautret P., Bussolino F., et al. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS‐inducing soluble factor. J Exp Med 1995; 182: 677–88
   PubMedGoogle Scholar
• Clark I. A., Al‐yaman F. M., Cowden W. B., Rockett K. A. Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa?. Lancet 1996; 348: 1492–4
   PubMed Web of Science ®Google Scholar
• Roitt I. M., Brostoff J., Male D. Immunology. 5th ed. Mosby Publications, LondonUK 1998
   Google Scholar
• Nahrevanian H., Dascombe M. J. Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasite Immunol 2001; 23: 491–501
   PubMedGoogle Scholar
• Grau G., Piguet P. F., Pointaire P. Cytokines and malaria; duality of effects in pathology and protection. Cytokines in health and disease, S. L Kunkel, D. G Remick. Marcel Dekker, Inc., USA, New York 1992; 197–213
   Google Scholar
• Jacobs P., Radzioch D., Stevenson M. M. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin‐4, during blood stage malaria in mice. Infect Immun 1996; 64: 44–9
   PubMedGoogle Scholar
• Cramer J. P., Mockenhaupt F. P., Ehrhardt S., Burkhardt J., Otchwemah R. N., Dietz E., et al. iNOS promoter variants and severe malaria in Ghanaian children. Trop Med Int Health 2004; 9: 1074–80
   PubMedGoogle Scholar
• Rockett K. A., Awburn M. M., Cowden W. B., Clark I. A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 1991; 59: 3280–3
   PubMed Web of Science ®Google Scholar
• Motard A., Landau I., Nussler A., Grau G., Baccam D., Mazier D., et al. The role of reactive nitrogen intermediates in modulation of gametocyte infectivity of rodent malaria parasites. Parasite Immunol 1993; 15: 21–6
   PubMed Web of Science ®Google Scholar
• Jones I. W., Thomsen L. L., Knowles R., Gutteridge W. E., Butcher G. A., Sinden R. E. Nitric oxide synthase activity in malaria‐infected mice. Parasite Immunol 1996; 18: 535–8
   PubMedGoogle Scholar
• Favre N., Ryffel B., Rudin W. The development of murine CM does not require nitric oxide production. Parasitology 1999a; 118: 135–8
   PubMed Web of Science ®Google Scholar
• Favre N., Ryffel B., Rudin W. Parasite killing in murine malaria does not require nitric oxide production. Parasitology 1999b; 118: 139–43
   PubMedGoogle Scholar
• Balmer P., Phillips H. M., Maestre A. E., McMonagle F. A., Phillips R. S. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro. . Parasite Immunol 2000; 22: 97–106
   PubMedGoogle Scholar
• Nahrevanian H., Dascombe M. J. Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non‐lethal strains of murine malaria. Parasite Immunol 2002; 24: 471–8
   PubMedGoogle Scholar
• Dascombe M. J., Nahrevanian H. Pharmacological assessment of the role of nitric oxide in mice infected with lethal and nonlethal species of malaria. Parasite Immunol 2003; 25: 149–59
   PubMedGoogle Scholar
• Nahrevanian H., Dascombe M. J. The role of nitric oxide and its up/downstream molecules in malaria; cytotoxic or preventive?. SE Asian J Trop Med Pub Health 2003; 34: 44–50
   PubMedGoogle Scholar
• Al‐yaman F. M., Mokela D., Genton B., Rockett K. A., Alpers M. P., Clark I. A. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 1996; 90: 270–3
   PubMed Web of Science ®Google Scholar
• Anstey N. M., Hassanali M. Y., Mwaikambo E. D., Manyenga D., Mlalasi J., Weinberg J. B., . Nitric oxide appears protective in Tanzanian children with malaria: evidence for increased NO production in subclinical infection and suppressed production in clinical and cerebral malaria. The biology of nitric oxide, S Moncada, J Stamler, S Gross, E. A Higgs, et al. Portland Press, LondonUK 1996; 150
   Google Scholar
• Snounou G., Viriyakosol S., Jarra W., Thaithong S., Brown K. N. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993; 58: 283–92
   PubMed Web of Science ®Google Scholar
• Rockett K. A., Awburn M. M., Rockett E. J., Cowden W. B., Clark I. A. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol 1994; 16: 243–9
   PubMed Web of Science ®Google Scholar
• Lopansri B. K., Anstey N. M., Weinberg J. B., Stoddard G. J., Hobbs M. R., Levesque M. C., et al. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 2003; 361: 676–8
   PubMed Web of Science ®Google Scholar
• Gyan B., Kurtzhals J. A. L., Akanmori B. D., Ofori M., Goka B. Q., Hviid L., et al. Elevated levels of nitric oxide and low levels of haptoglobin are associated with severe anaemia in African children. Acta Trop 2002; 83: 133–40
   PubMedGoogle Scholar
• Clark I. A., Awburn M. M., Whitten R. O., Harper C. G., Liomba N. G., Molyneux M. E., et al. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malaria J 2003; 2: 1–17
   PubMedGoogle Scholar
• Boutlis C. S., Tjitra E., Maniboey H., Misukonis M. A., Saunders J. R., Suprianto S., et al. Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria‐tolerant Papuan adults. Infect Immun 2003; 71: 3682–9
   PubMedGoogle Scholar
• Boutlis C. S., Weinberg J. B., Baker J., Bockarie M. J., Mgone C. S., Cheng Q., et al. Nitric oxide production and nitric oxide synthase activity in malaria‐exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitaemia. Infect Immun 2004; 72: 6932–8
   PubMedGoogle Scholar
• Becker K., Tilley L., Vennerstrom J. L., Roberts D., Rogerson S., Ginsburg H. Oxidative stress in malaria parasite infected erythrocytes: host‐parasite interactions. Int J Parasitol 2004; 34: 163–89
   PubMed Web of Science ®Google Scholar
• Taylor A. M., Day N. P. J., Sinh D. X. T., Loc P. P., Mai T. T. H., Chau T. T., et al. Reactive nitrogen intermediates and outcome in severe adult malaria. Curr Opin Immunol 1995; 7: 396–9
   PubMedGoogle Scholar
• Mackintosh C. L., Beeson J. G., Marsh K. Clinical features and pathogenesis of severe malaria. Trends Parasitol 2004; 20: 597–603
   PubMed Web of Science ®Google Scholar
• Kun J. F. Regulation of nitrogen monoxide production in human malaria. Redox Rep 2003; 8: 289–91
   PubMed Web of Science ®Google Scholar
• Xu W., Humpheries S., Tomita M., Okuyama T., Matsuki M., Burgner D., et al. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide 2000; 4: 379–83
   PubMedGoogle Scholar